Clinical Trial Update: Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioequivalence and safety of Vantobra versus TOBI in healthy subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI (Tobramycin inhalation solution)
• Vantobra

Snippet

Sponsor: Pari Pharma GmbH | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED